Arovella Therapeutics Ltd. announced that it has appointed Mr. Gary Phillips, MBA, GAICD, as an independent Non-executive Director. Mr. Phillips has more than 30 years of operational management experience in the pharmaceutical and healthcare industry in Europe, Asia and Australia. He is currently the CEO and Managing Director of the ASX-listed company, Pharmaxis.

Following his appointment as Pharmaxis CEO, Mr. Phillips has overseen a company restructure focused on building value, forging new partnerships, and fostering the development of the Pharmaxis product pipeline. Prior to joining Pharmaxis, he was previously the CEO at Ciba Geigy in Hungary where he led the successful launch of a portfolio of new products. Mr. Phillips was Novartis' area manager covering nine countries across Asia Pacific before joining Novartis Australia as Group Company Head and Chief Executive Officer of its Pharmaceutical Division, successfully launching leading oncology and ophthalmology products.

Gary Phillips holds a Bachelor of Pharmacy Honours degree from Nottingham University in the U.K. and an MBA from Henley Management College, UK. Mr. Phillips is also a Graduate of the Australian Institute of Company Directors (GAICD).